Regular Articles
Survival after pancreaticoduodenectomy for periampullary adenocarcinoma: an update

https://doi.org/10.1053/ejso.2001.1162Get rights and content

Abstract

Aim: Survival after pancreaticoduodenectomy for periampullary tumours is limited. Over the last decade peri-operative management has improved and morbidity and mortality decreased. The aim of the study was to analyse recent survival data after pancreaticoduodenectomy and to determine factors that influence survival. Methods: From October 1992 to September 1998, 204 patients with a ductal adenocarcinoma in the pancreatic head (108), distal bile duct (32), and ampulla (64) who underwent standard pancreaticoduodenectomy, were analysed with regard to histology and tumour status. Survival was calculated by using the Kaplan–Meier method. Risk factors were identified in a univariate and multivariate analysis. Results: Median survival after resection for carcinoma of the pancreatic head, distal bile duct, and ampulla were 16*, 25 and 24* months, respectively (*P=0.008). In the univariate analysis vein resection, blood transfusion of more than four packed red cells, the presence of tumour positive resection margins, lymph-node metastases and poor tumour differentiation significantly decreased survival. In the multivariate analysis positive resection margins, lymph-node metastases, and poor tumour differentiation independently influenced survival. Conclusions: Resection margins, lymph-node status and tumour differentiation are independent prognostic factors. Survival after standard pancreaticoduodenectomy for periampullary tumours has not improved.

References (51)

  • CL Yeo et al.

    Periampullary adenocarcinoma: analysis of 5-year survivors

    Ann Surg

    (1998)
  • B Gudjonsson

    Carcinoma of the pancreas: critical analysis of costs, results of resections, and the need for standardized reporting [see comments]

    J Am College Surgeons

    (1995)
  • HP Tan et al.

    Pancreatic adenocarcinoma: an update

    J Am College Surgeons

    (1996)
  • JR Howe et al.

    Factors predictive of survival in ampullary carcinoma

    Ann Surg

    (1998)
  • KD Lillemoe

    Current management of pancreatic carcinoma

    Ann Surg

    (1995)
  • M Trede et al.

    Survival after pancreatico- duodenectomy. 118 consecutive resections without an operative mortality

    Ann Surg

    (1990)
  • SS Nitecki et al.

    Long-term survival after resection for ductal adenocarcinoma of the pancreas. Is it really improving?

    Ann Surg

    (1995)
  • DJ Gouma et al.

    Complications, hospital mortality and survival following partial pancreaticoduodenectomy. [Dutch]

    Nederlands Tijdschrift Geneeskunde

    (1997)
  • DJ Gouma et al.

    Rates of complications and death after pancreaticoduodenectomy: risk factors and the impact of hospital volume

    Ann Surg

    (2000)
  • CJ Yeo et al.

    Six hundred and fifty consecutive pancreaticoduodenectomies in the 1990s: pathology, complications, and outcomes

    Ann Surg

    (1997)
  • CC Fernandez-del et al.

    Standards for pancreatic resection in the 1990s

    Arch Surg

    (1995)
  • CA Pellegrini et al.

    An analysis of the reduced morbidity and mortality rates after pancreatico-duodenectomy

    Arch Surg

    (1989)
  • JL Cameron et al.

    Factors influencing survival after pancreaticoduodenectomy for pancreatic cancer

    Am J Surg

    (1991)
  • S Vedantham et al.

    Small peripancreatic veins: improved assessment in pancreatic cancer patients using thin-section pancreatic phase helical CT

    Am J Roentgenol

    (1998)
  • SJ Diehl et al.

    Pancreatic cancer: value of dual-phase helical CT in assessing resectability

    Radiology

    (1998)
  • Cited by (71)

    • Advanced small bowel adenocarcinoma: Molecular characteristics and therapeutic perspectives

      2016, Clinics and Research in Hepatology and Gastroenterology
      Citation Excerpt :

      The intestinal subtype was defined as having positive staining for CK20 or CDX2 or MUC2 and negative staining for MUC1, or positive staining for CK20, CDX2, and MUC2, irrespective of the MUC1 status; whereas the pancreatobiliary subtype was defined as having positive staining for MUC1 and negative staining for CDX2 and MUC2, whatever the CK20 results [31]. For patients with ampullary adenocarcinoma who undergo surgical resection, survival is similar to that observed in patients with resected duodenal adenocarcinoma, rather than in those with resected pancreatico-biliary carcinomas [32,33]. Gemcitabine or 5-fluorouracil adjuvant-based chemotherapy seems to be associated with a significant survival benefit in patients with periampullary adenocarcinoma [34].

    • Pancreatoduodenectomy associated complications influence cancer recurrence and time interval to death

      2014, European Journal of Surgical Oncology
      Citation Excerpt :

      Our finding that postoperative complications are independently associated with death due to recurrence in pancreatic cancer might therefore better appreciated as earlier death due to recurrence. For pancreatic and periampullary adenocarcinoma several operation characteristics and pathological determinants have been demonstrated to influence long-term survival.21,27,28 Our study reconfirms the prognostic value of variables as resection margin status, lymph node metastasis or lymph node ratio, and tumour differentiation grade.

    View all citing articles on Scopus

    Correspondence to: D. J. Gouma, MD, Academic Medical Center, Department of Surgery, Meibergdreef 9, PO Box 22660, 1100 DD Amsterdam, The Netherlands. Fax: +3120 691 48 58;E-mail: [email protected]

    View full text